RIPLET, and not TRIM25, is required for endogenous RIG-I-dependent antiviral responses

- Hayman, Thomas J., Hsu, Alan C., Wark, Peter A., Kedzierska, Katherine, Masters, Seth L., Belz, Gabrielle T., Binder, Marco, Hansbro, Philip M., Nicola, Nicos A., Nicholson, Sandra E., Kolesnik, Tatiana B., Dagley, Laura F., Willemsen, Joschka, Tate, Michelle D., Baker, Paul J., Kershaw, Nadia J., Kedzierski, Lukasz, Webb, Andrew I.

Suppressor of cytokine signaling (SOCS)5 ameliorates influenza infection via inhibition of EGFR signaling

- Kedzierski, Lukasz, Tate, Michelle D., Bird, Nicola L., Chatfield, Simon M., Babon, Jeffrey J., Huntington, Nicholas, Belz, Gabrielle, Webb, Andrew, Wark, Peter A. B., Nicola, Nicos A., Xu, Jianqing, Kedzierska, Katherine, Hsu, Alan C., Hansbro, Philip M., Nicholson, Sandra E., Kolesnik, Tatiana B., Linossi, Edmond M., Dagley, Laura, Dong, Zhaoguang, Freeman, Sarah, Infusini, Giuseppe, Starkey, Malcolm R.

Defining the distinct, intrinsic properties of the novel type I interferon, IFNϵ.

- Stifter, Sebastian A., Matthews, Antony Y., Garcia Minambres, Albert, Eid, Sahar G., Mak, Johnson, Scoble, Judy, Lovrecz, George, deWeerd, Nicole A., Hertzog, Paul J., Mangan, Niamh E., Fung, Ka Yee, Drew, Alexander, Tate, Michelle D., Soares da Costa, Tatiana P., Hampsey, Daniel, Mayall, Jemma, Hansbro, Phil M.